Read more
Darwin¿EUR¿s Medicine examines how pharmaceutical, medical technology and other companies are adapting their strategies, structures, capabilities and other aspects of their business model. In this sequel to his successful
The Future of Pharma (Gower, 2011), Brian Smith takes a global perspective, reflecting the nature of the industr
List of contents
Part 1: The Future of Pharma - Reprise 1. Introduction and an Invitation to Skip a Chapter
2. An Important Industry at Risk
3. The Best Idea Anyone Has Ever Had
4. The Biologists Got There First
5. Applying Evolutionary Theory to the Pharmaceutical and Medical Technology Sectors
6. Explaining the Industry¿EUR¿s Past
7. Predicting the Future of Pharma and Medtech
8. Practical Implications for an Evolving Industry
9. Watching the Future Unfold
Part 2: An Immeasurably Superior Power 10. Introduction: The Emergent Pressures of Selection
11. Selection Pressures Emerging from the Social Environment
12. Selection Pressures Emerging from the Technological Environment
13. Asking the Right Questions
Part 3: Evolution is Cleverer Than You Are 14. Introduction: Orgel¿EUR¿s Second Law
15. Technological Innovator Species Emerging in the Government Payer Habitat
16. Technological Innovator Species Emerging in Patient Payer Habitats
17. Operationally Excellent Species Emerging in the Government Payer Habitat
18. Operationally Excellent Species Emerging in Patient Payer Habitats
19. Customer Intimate Species Emerging in the Government Payer Habitat
20. Customer Intimate Species Emerging in Patient Payer Habitats
21. A Big Bang of Life Science Business Models
Part 4: Guiding the Blind Watchmaker 22. Introduction: From Description to Prescription
23. Which Fitness Peak(s) Should We Climb?
24. What Capabilities Does Our New Business Model Need?
25. How Should We Design a Capable Holobiont?
26. How Do We Build Our Core Capabilities?
About the author
Professor Brian D. Smith began his career as a research chemist in a pharmaceutical R&D lab and then spent 20 years in technical and marketing roles before becoming an academic, author and adviser. Working at The University of Hertfordshire and SDA Bocconi, two of Europe's leading business schools, his research focuses on strategy creation and implementation in pharmaceutical and medical technology markets. Brian also runs a specialist consultancy that advises many of the world's largest companies in this sector. He is editor of the
Journal of Medical Marketing, has written and co-written three major books, including
The Future of Pharma (Gower, 2011), and published many practitioner articles - all of which can be seen at www.pragmedic.com.
Summary
Darwin?€?s Medicine examines how pharmaceutical, medical technology and other companies are adapting their strategies, structures, capabilities and other aspects of their business model. In this sequel to his successful The Future of Pharma (Gower, 2011), Brian Smith takes a global perspective, reflecting the nature of the industr
